Evaluation of PENG Block in Terms of Block Time and Postoperative Pain

NCT06132308 | Completed

• 1 other identifier: Diskapı-YB-SA-PENG
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 2

Brief Summary

Hip fracture is a common orthopedic emergency in the elderly and causes significant morbidity and is associated with mortality. In most patients, surgical reduction and fixation is the definitive treatment. Effective perioperative analgesia minimizing the need for opioids and related side effects is recommended in this patient population. Therefore, various methods are used. When the investigators look at the literature, for PENG block It is observed that different drug doses (20cc, 30cc, and 40cc) are used. In this study, the investigators planned to investigate the effectiveness of PENG blocks, postoperative analgesia, and side effects.

Conditions

Postoperative Pain

Keywords

PENG; Hip fracture

Outcome Measures

Primary Outcomes (5)

• The degree of postoperative pain

  The degree of pain will be measured with numerical rating scale (NRS). All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups.

  0 hour

• The degree of postoperative pain

  The degree of pain will be measured with numerical rating scale (NRS). All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups.

  4 hour

• The degree of postoperative pain

  The degree of pain will be measured with numerical rating scale (NRS). All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups.

  8 hour

• The degree of postoperative pain

  The degree of pain will be measured with numerical rating scale (NRS). All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups.

  24 hour

• Postoperative tramadol consumption

  total tramadol consumption in three groups will be assessed in the postoperative period

  24 hour

Study Arms (3)

PENG Block with 0.25% bupivacaine (20 cc)

ACTIVE COMPARATOR

For PENG block, patients are in the supine position is deposited. The convex ultrasound probe is initially placed over the anterior superior iliac spine, then the probe moves medially until the femoral artery is visualized. In this view, iliopectineal eminence (IPE), iliopsoas muscle and tendon, femoral artery and iliac muscle are observed. Between the psoas tendon and the IPE 22 gauge 80 mm block needle is guided and 20cc local anesthetic used in % 0.25 bupivacaine is administered by intermittent aspiration.

Procedure: PENG Block with 0.25% bupivacaine

PENG Block with 0.25% bupivacaine (30 cc)

EXPERIMENTAL

For PENG block, patients are in the supine position is deposited. The convex ultrasound probe is initially placed over the anterior superior iliac spine, then the probe moves medially until the femoral artery is visualized. In this view, iliopectineal eminence (IPE), iliopsoas muscle and tendon, femoral artery and iliac muscle are observed. Between the psoas tendon and the IPE 22 gauge 80 mm block needle is guided and 30cc local anesthetic used in % 0.25 bupivacaine is administered by intermittent aspiration.

Procedure: PENG Block with 0.25% bupivacaine

PENG Block with 0.25% bupivacaine (40 cc)

EXPERIMENTAL

For PENG block, patients are in the supine position is deposited. The convex ultrasound probe is initially placed over the anterior superior iliac spine, then the probe moves medially until the femoral artery is visualized. In this view, iliopectineal eminence (IPE), iliopsoas muscle and tendon, femoral artery and iliac muscle are observed. Between the psoas tendon and the IPE 22 gauge 80 mm block needle is guided and 40cc local anesthetic used in % 0.25 bupivacaine is administered by intermittent aspiration.

Procedure: PENG Block with 0.25% bupivacaine

Interventions

PENG Block with 0.25% bupivacaine PROCEDURE

Peng block was performed.

PENG Block with 0.25% bupivacaine (20 cc); PENG Block with 0.25% bupivacaine (30 cc); PENG Block with 0.25% bupivacaine (40 cc)

Eligibility Criteria

• Age: 40 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \- Patients who have undergone hip surgery with PENG block for any reason

You may not qualify if:

• chronic opioid users
• cognitive disorders
• written consent form haven't get
• history of relevant drug allergy
• infection of the skin at the site of needle puncture area
• coagulopathy

Sponsors & Collaborators

• Diskapi Yildirim Beyazit Education and Research Hospital: lead

Study Sites (2)

Department of Anesthesiology and Reanimation, University of Health Sciences, Diskapi Yıldırım Beyazit Training and Research Hospital

Ankara, 06450, Turkey (Türkiye)

Location

university of health siences diskapi yildirim beyazit T&R hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative; Hip Fractures

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms; Femoral Fractures; Fractures, Bone; Wounds and Injuries; Hip Injuries; Leg Injuries

Intervention Hierarchy (Ancestors)

Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: PREVENTION
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: March 17, 2023
• First Posted: November 15, 2023
• Study Start: October 15, 2023
• Primary Completion: July 2, 2024
• Study Completion: August 10, 2024
• Last Updated: November 5, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (2)